RS

Rajib Sengupta

Director Director DIN 06991491
DIN 06991491 First appointment Jun 2015 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jun 2015
Shareholding value Locked Premium profile

About Rajib Sengupta

Data last updated:

Rajib Sengupta has 11 years in corporate governance. Formerly with 1 company, such as Arogya Medtech Private Limited. Engaged in Technology. Contributes to corporate operations.

DIN 06991491
Primary Designation Director
First Appointment 18 Jun 2015
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Arogya Medtech Private Limited U33111WB2015PTC206772
Director18 Jun 20152015Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Arogya Medtech Private Limited
Premium access

Shareholding and investment profile for Rajib Sengupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajib Sengupta

Rajib Sengupta has 11 years in corporate governance. Formerly with 1 company, such as Arogya Medtech Private Limited. Engaged in Technology. Contributes to corporate operations.

Rajib Sengupta is associated with 0 companies as a director.

Rajib Sengupta has expertise in Technology.

Rajib Sengupta has 11 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available